Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain
- PMID: 16021679
- DOI: 10.1002/jat.1053
Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain
Abstract
The potency of currently used oximes to reactivate sarin-inhibited acetylcholinesterase (AChE) in various parts of pig brain and whole pig brain was evaluated using in vitro methods. Significant differences in reactivation potency among all tested oximes were observed. At concentrations (10(-4) M) corresponding to recommended doses in vivo, the oxime HI-6 seems to be a more efficacious reactivator of sarin-inhibited AChE in whole pig brain as well as in cerebral hemispheres and cerebellum compared with the other oximes studied. Nevertheless, there are not any differences in the potency of oximes tested to reactivate sarin-inhibited AChE in medulla oblongata. Thus, the oxime HI-6 appears to be the most promising oxime among currently available oximes for the antidotal treatment of acute sarin poisoning, although it is not more efficacious than other currently used oximes in medulla oblongata, whose function is necessary for the vital functions of respiration and circulation.
Similar articles
-
A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.Pharmazie. 2004 Oct;59(10):795-8. Pharmazie. 2004. PMID: 15544060
-
A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.Acta Medica (Hradec Kralove). 2005;48(2):81-6. Acta Medica (Hradec Kralove). 2005. PMID: 16259317
-
A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods.J Toxicol Environ Health A. 2005 Apr 23;68(8):677-86. doi: 10.1080/15287390590921784. J Toxicol Environ Health A. 2005. PMID: 15901095
-
Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.Clin Med Res. 2007 Mar;5(1):71-82. doi: 10.3121/cmr.2007.701. Clin Med Res. 2007. PMID: 17456837 Free PMC article. Review.
-
Role of edrophonium in prevention of the re-inhibition of acetylcholinesterase by phosphorylated oxime.Chem Biol Interact. 1999 May 14;119-120:129-35. doi: 10.1016/s0009-2797(99)00021-6. Chem Biol Interact. 1999. PMID: 10421446 Review.
Cited by
-
Molecular Modeling Study of Uncharged Oximes Compared to HI-6 and 2-PAM Inside Human AChE Sarin and VX Conjugates.ACS Omega. 2020 Feb 26;5(9):4490-4500. doi: 10.1021/acsomega.9b03737. eCollection 2020 Mar 10. ACS Omega. 2020. PMID: 32175496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources